Ashley Bouknight

NPI: 1205440351
Total Payments
$7,544
2024 Payments
$1,895
Companies
29
Transactions
426
Medicare Patients
1,405
Medicare Billing
$110,660

Payment Breakdown by Category

Food & Beverage$7,522 (99.7%)
Education$22.12 (0.3%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $7,522 425 99.7%
Education $22.12 1 0.3%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $3,995 194 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $591.34 52 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $485.05 27 $0 (2024)
Celgene Corporation $426.05 42 $0 (2024)
Janssen Biotech, Inc. $344.90 23 $0 (2024)
Merck Sharp & Dohme LLC $226.68 16 $0 (2024)
Regeneron Healthcare Solutions, Inc. $174.02 10 $0 (2024)
QOL Medical, LLC $156.21 8 $0 (2024)
Ardelyx, Inc. $148.10 8 $0 (2023)
Janssen Scientific Affairs, LLC $120.72 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,895 107 ABBVIE INC. ($988.81)
2023 $1,619 97 ABBVIE INC. ($583.07)
2022 $2,025 119 ABBVIE INC. ($1,173)
2021 $2,005 103 AbbVie Inc. ($1,250)

All Payment Transactions

426 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
12/18/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug), XIFAXAN Food and Beverage In-kind items and services $15.75 General
Category: Gastroenterology
12/18/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $14.34 General
Category: IMMUNOLOGY
12/17/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $14.39 General
12/16/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $22.91 General
Category: IMMUNOLOGY
12/12/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $13.50 General
Category: GASTROENTEROLOGY
12/11/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $26.05 General
Category: LIVER DISEASE
12/09/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $21.28 General
Category: Immunology
12/06/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $32.89 General
Category: INTERNAL MEDICINE
12/05/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $5.28 General
Category: GASTROENTEROLOGY
12/04/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $22.73 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
12/02/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $21.27 General
Category: GI
11/25/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $32.50 General
Category: Immunology
11/25/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $2.93 General
Category: IMMUNOLOGY
11/13/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $1.66 General
Category: ENDOCRINOLOGY
11/11/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $26.92 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
10/31/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $22.92 General
Category: INTERNAL MEDICINE
10/29/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $26.90 General
Category: IMMUNOLOGY
10/28/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $21.27 General
Category: IMMUNOLOGY
10/24/2024 ABBVIE INC. CREON (Drug), LINZESS Food and Beverage In-kind items and services $12.75 General
Category: ENDOCRINOLOGY
10/23/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $15.09 General
Category: IMMUNOLOGY
10/22/2024 ABBVIE INC. RINVOQ (Biological) Food and Beverage In-kind items and services $122.19 General
Category: IMMUNOLOGY
10/22/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $27.81 General
Category: LIVER DISEASE
10/16/2024 ABBVIE INC. MAVYRET (Drug) Food and Beverage In-kind items and services $15.17 General
Category: VIROLOGY
10/14/2024 ABBVIE INC. RINVOQ (Biological), SKYRIZI Food and Beverage In-kind items and services $16.22 General
Category: IMMUNOLOGY
10/14/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $7.09 General
Category: GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 472 585 $175,236 $37,152
2022 5 491 550 $166,274 $35,584
2021 6 442 513 $154,645 $37,925
Total Patients
1,405
Total Services
1,648
Medicare Billing
$110,660
Procedure Codes
16

All Medicare Procedures & Services

16 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 164 202 $68,575 $14,901 21.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 184 259 $61,725 $12,558 20.3%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 73 73 $32,517 $6,912 21.3%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 34 34 $9,910 $2,180 22.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 17 17 $2,509 $600.10 23.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 204 259 $61,725 $13,345 21.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 125 125 $55,680 $11,836 21.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 93 97 $32,930 $7,304 22.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 40 40 $11,659 $2,340 20.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 29 29 $4,280 $759.63 17.7%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 120 120 $53,453 $12,277 23.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 117 136 $42,329 $10,835 25.6%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 135 186 $42,672 $10,400 24.4%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 33 33 $9,583 $2,369 24.7%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 17 17 $3,544 $1,325 37.4%
99212 Established patient outpatient visit, total time 10-19 minutes Office 2021 20 21 $3,065 $718.60 23.4%

About Ashley Bouknight

Ashley Bouknight is a Family healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/06/2020. The National Provider Identifier (NPI) number assigned to this provider is 1205440351.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Bouknight has received a total of $7,544 in payments from pharmaceutical and medical device companies, with $1,895 received in 2024. These payments were reported across 426 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,522).

As a Medicare-enrolled provider, Bouknight has provided services to 1,405 Medicare beneficiaries, totaling 1,648 services with total Medicare billing of $110,660. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Location Oklahoma City, OK
  • Active Since 09/06/2020
  • Last Updated 09/06/2020
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1205440351

Products in Payments

  • HUMIRA (Biological) $1,155
  • RINVOQ (Biological) $915.89
  • CREON (Drug) $700.82
  • SKYRIZI (Biological) $683.91
  • ZEPOSIA (Drug) $504.09
  • XIFAXAN (Drug) $432.36
  • STELARA (Biological) $429.85
  • LINZESS (Drug) $276.54
  • ENTYVIO (Biological) $244.20
  • DIFICID (Drug) $226.68
  • GATTEX (Drug) $226.68
  • DUPIXENT (Biological) $219.26
  • TRULANCE (Drug) $158.98
  • ZENPEP (Drug) $155.48
  • IBSRELA (Drug) $148.10
  • MAVYRET (Drug) $104.71
  • VIBERZI (Drug) $87.47
  • SUCRAID (Drug) $85.93
  • INJECTAFER (Drug) $73.28
  • Sucraid (Drug) $70.28

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Oklahoma City